Matches in Wikidata for { <http://www.wikidata.org/entity/Q43923016> ?p ?o ?g. }
- Q43923016 description "2013 nî lūn-bûn" @default.
- Q43923016 description "2013 թվականի սեպտեմբերի 4-ին հրատարակված գիտական հոդված" @default.
- Q43923016 description "2013年の論文" @default.
- Q43923016 description "2013年学术文章" @default.
- Q43923016 description "2013年学术文章" @default.
- Q43923016 description "2013年学术文章" @default.
- Q43923016 description "2013年学术文章" @default.
- Q43923016 description "2013年学术文章" @default.
- Q43923016 description "2013年学术文章" @default.
- Q43923016 description "2013年學術文章" @default.
- Q43923016 description "2013年學術文章" @default.
- Q43923016 description "2013年學術文章" @default.
- Q43923016 description "2013年學術文章" @default.
- Q43923016 description "2013年學術文章" @default.
- Q43923016 description "2013년 논문" @default.
- Q43923016 description "article científic" @default.
- Q43923016 description "article scientific" @default.
- Q43923016 description "article scientifique" @default.
- Q43923016 description "articol științific" @default.
- Q43923016 description "articolo scientifico" @default.
- Q43923016 description "artigo científico" @default.
- Q43923016 description "artigo científico" @default.
- Q43923016 description "artigo científico" @default.
- Q43923016 description "artikel ilmiah" @default.
- Q43923016 description "artikull shkencor" @default.
- Q43923016 description "artikulong pang-agham" @default.
- Q43923016 description "artykuł naukowy" @default.
- Q43923016 description "artículo científico publicado en 2013" @default.
- Q43923016 description "artículu científicu espublizáu en 2013" @default.
- Q43923016 description "bilimsel makale" @default.
- Q43923016 description "bài báo khoa học" @default.
- Q43923016 description "naučni članak" @default.
- Q43923016 description "scienca artikolo" @default.
- Q43923016 description "scientific article published on 4 September 2013" @default.
- Q43923016 description "scientific article published on 4 September 2013" @default.
- Q43923016 description "scientific article published on 4 September 2013" @default.
- Q43923016 description "teaduslik artikkel" @default.
- Q43923016 description "tieteellinen artikkeli" @default.
- Q43923016 description "tudományos cikk" @default.
- Q43923016 description "vedecký článok" @default.
- Q43923016 description "vetenskaplig artikel" @default.
- Q43923016 description "videnskabelig artikel" @default.
- Q43923016 description "vitenskapelig artikkel" @default.
- Q43923016 description "vitskapeleg artikkel" @default.
- Q43923016 description "vědecký článek" @default.
- Q43923016 description "wetenschappelijk artikel" @default.
- Q43923016 description "wissenschaftlicher Artikel" @default.
- Q43923016 description "επιστημονικό άρθρο" @default.
- Q43923016 description "мақолаи илмӣ" @default.
- Q43923016 description "наукова стаття, опублікована у вересні 2013" @default.
- Q43923016 description "научна статия" @default.
- Q43923016 description "научная статья" @default.
- Q43923016 description "научни чланак" @default.
- Q43923016 description "научни чланак" @default.
- Q43923016 description "מאמר מדעי" @default.
- Q43923016 description "مقالة علمية نشرت في 4 سبتمبر 2013" @default.
- Q43923016 description "৪ সেপ্টেম্বর ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q43923016 description "บทความทางวิทยาศาสตร์" @default.
- Q43923016 description "სამეცნიერო სტატია" @default.
- Q43923016 name "Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN)." @default.
- Q43923016 name "Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN)." @default.
- Q43923016 type Item @default.
- Q43923016 label "Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN)." @default.
- Q43923016 label "Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN)." @default.
- Q43923016 prefLabel "Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN)." @default.
- Q43923016 prefLabel "Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN)." @default.
- Q43923016 P1433 Q43923016-0F4CF5C7-13DB-4BEF-A49D-5EEEF4334EB9 @default.
- Q43923016 P1476 Q43923016-9660EDEC-4767-4E4A-BB7F-64BAC77CC06F @default.
- Q43923016 P2093 Q43923016-41FCA397-0C83-488B-8677-F1DAF7E050B3 @default.
- Q43923016 P2093 Q43923016-E2E4F250-C925-4500-8361-CC908CC34903 @default.
- Q43923016 P304 Q43923016-D543A6FC-D5A2-41A9-983C-4739BABC42DB @default.
- Q43923016 P31 Q43923016-4C49D08B-132A-40DF-9A04-B02F703394F6 @default.
- Q43923016 P356 Q43923016-2BD1C750-0AA3-4DCD-9133-FA17F6FF3B77 @default.
- Q43923016 P407 Q43923016-384E82BB-691A-4AAB-9CC7-0B903FAF50BC @default.
- Q43923016 P433 Q43923016-49E52098-339A-4A40-B338-0BAAA28D66A7 @default.
- Q43923016 P478 Q43923016-86E68813-54C0-41C6-81DC-7D2B0EC23675 @default.
- Q43923016 P50 Q43923016-0C12D56D-5289-419F-AD26-4B227EEB9DD1 @default.
- Q43923016 P50 Q43923016-1AD4C076-EEFC-49CF-B496-047B8D9DD906 @default.
- Q43923016 P50 Q43923016-4595F257-38A9-452F-B86A-29A9CA8EA0DD @default.
- Q43923016 P50 Q43923016-5CA944F3-48A5-4F85-A744-6D6B83B58894 @default.
- Q43923016 P50 Q43923016-686175C2-2CDF-4A34-AEE6-C33064636275 @default.
- Q43923016 P50 Q43923016-8A8B3422-20AD-415E-A049-5D832473EEBA @default.
- Q43923016 P50 Q43923016-90E55D00-3558-4423-BA1F-55D532C80FBB @default.
- Q43923016 P50 Q43923016-9B1A9040-3CB6-4527-AD2A-4F53527F6B23 @default.
- Q43923016 P50 Q43923016-9E2B8011-6C77-4421-8B82-D20C12B94C4C @default.
- Q43923016 P50 Q43923016-AD385D5C-3C8B-45B9-9AED-072C2A54D14C @default.
- Q43923016 P50 Q43923016-BD7DF247-2EA8-4934-8B54-F39BA449FA83 @default.
- Q43923016 P50 Q43923016-CCEB2181-B043-4DB5-B494-74BADA0332C8 @default.
- Q43923016 P577 Q43923016-2932ED69-5A03-4187-B92E-86C477FB2203 @default.
- Q43923016 P5875 Q43923016-005574C2-790B-4A6B-B46A-5C3B80488E0F @default.
- Q43923016 P698 Q43923016-D7D42987-DACF-4E3F-96CF-FDAF6DC3F7CC @default.
- Q43923016 P8608 Q43923016-B847AD7B-8AD6-4BDA-B0A0-0F8A053E555F @default.
- Q43923016 P921 Q43923016-AEF54781-0CB1-49D1-8196-EA160317BE1D @default.
- Q43923016 P921 Q43923016-C554DF45-19E3-45CE-B309-5D5526AA7023 @default.
- Q43923016 P356 BLOOD-2013-05-503862 @default.
- Q43923016 P698 24004667 @default.
- Q43923016 P1433 Q885070 @default.
- Q43923016 P1476 "Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN)." @default.
- Q43923016 P2093 "Pierre Morel" @default.
- Q43923016 P2093 "Xavier Leleu" @default.